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In this issue, Gardam et al. (2008) show that BAFF, a tumor necrosis factor (TNF) family member, promotes
B cell survival by hindering interactions between TNF-receptor-associated factors, blocking their negative
regulation of nonclassical NF-kB activity.B cell-activating factor belonging to the
tumor necrosis factor family (BAFF) and
its close relative a proliferation-induc-
ing ligand (APRIL) are members of the
tumor necrosis factor (TNF) superfamily.
Through interactions with their receptors,
these two cytokines mediate the behavior
of most B cells. Among the three recep-
tors, BAFF receptor (BAFF-R) interacts
solely with BAFF and is the dominant re-
ceptor governing primary B cell survival.
In contrast, transmembrane activator and
calcium modulator and cyclophylin ligand
interactor (TACI) and B cell maturation
antigen (BCMA) can interact with both
APRIL and BAFF.
This family of ligands and receptors im-
pacts myriad B cell activities. BAFF inter-
actions with BAFF-R control primary B
cell selection, differentiation, and survival,
as evidenced by the B cell hyperplasia
and autoimmunity when BAFF is overex-
pressed or exogenously administered. In
addition, the appropriate initiation and
resolution of germinal center reactions,
isotype switching, and plasma cell sur-
vival are influenced by BAFF or APRIL,
presumably reflecting altered patterns of
BAFF family receptors and mediators
within antigen experienced B cell subsets.
Although several of the downstream com-
ponents important to these activities have
been identified, how so broad an array of
subset- and context-specific activities
can be mediated by a relatively small
group of ligands and receptors remains
elusive. In this issue of Immunity, Gardam
et al. (2008) provide insight into the mem-
brane-proximal events underlying the
survival promoting activity of BAFF-R.
They show that inhibition of heteromeric
TRAF interactions is one means by which
BAFF fosters survival via the nonclassical
NF-kB pathway. These findings not only
resolve relationships predicted by prior300 Immunity 28, March 2008 ª2008 Elsevierwork but also point toward a series
of layers in which varied permutations
of ligands, receptors, and substrates
can afford diverse and context-specific
outcomes.
As with most TNF receptors lacking
death domains, all three BAFF-binding re-
ceptors can engage at least one of the six
known TNF-receptor-associated factors
(TRAFs). Thus, BAFF-R contains a binding
site for TRAF3 only, whereas TACI has
sites for TRAF2, TRAF5, and TRAF6 and
BCMA has sites for TRAF1, TRAF2, and
TRAF3. Prior findings had already impli-
cated TRAF2 and TRAF3 in B cell survival,
through mechanisms influencing activa-
tion of both classical and nonclassical
NF-kB transcription-factor pathways, as
well as protein kinase C-d (PKC-d) reten-
tion (Grech et al., 2004; Xie et al., 2007).
Although the relationship to BAFF signal-
ing was not yet clear, these observations
were nonetheless provocative because
both of the NF-kB pathways and PKC-d
retention are known downstream contri-
butors to BAFF-mediated survival (Enzler
et al., 2006; Hatada et al., 2003; Sasaki
et al., 2006). In particular, the survival-
promoting effects of BAFF via BAFF-R
binding rely on the nonclassical arm of
the NF-kB transcription factors. This
pathway proceeds via the phosphoryla-
tion of p100 initiated by NF-kB-inducing
kinase (NIK), targeting p100 for ubi-
quitination and partial degradation. The
resulting p52 product, along with its
heterodimeric partner, RelB, translocates
to the nucleus to mediate prosurvival
transcriptional programs.
By using B lineage-specific conditional
knockouts for the genes encoding
TRAF2 and TRAF3, Gardam et al. (2008)
now show that the lack of either or both
of these adapters yields enlarged follicular
and marginal-zone B cell pools, reminis-Inc.cent of the phenotypes observed when
BAFF is overexpressed or exogenously
administered. Moreover, B cells from
these deletion mutants display enhanced
constitutive nonclassical NF-kB activa-
tion, as evidenced by decreases in cytpo-
plasmic p100 and corresponding
increases in the amounts of nuclear p52
and RelB. Importantly, in contrast to the
B cells from BAFF-overexpressing trans-
genics, these cells exhibit prolonged and
BAFF-independent survival in vitro, indi-
cating that a cell-intrinsic negative regula-
tory circuit that normally opposes BAFF
action has been ablated. Finally, they
show that this relationship to survival
only holds in the context of the B cell, be-
cause similarly ablating TRAF2 or TRAF3
in T cells alters neither their survival pro-
perties nor pool sizes, despite enhancing
nonclassical NF-kB activation.
On the basis of these findings, Gardam
et al. (2008) propose a model whereby
interactions between TRAF2 and TRAF3
constitutively thwart B cell survival by
inhibiting activation of the nonclassical
NF-kB pathway. This likely reflects a me-
chanism whereby NIK accumulation is
prevented, because NIK bears a TRAF3
interaction site and can be marked for
degradation by TRAF3. In the scenario
proposed, when BAFF-R is occupied by
BAFF, it sequesters TRAF3, preventing in-
teractions with TRAF2. This would afford
greater NIK accumulation, subsequent
NF-kB2 processing, and hence B cell sur-
vival. This model raises the intriguing
question of whether apoptosis is an intrin-
sic default pathway for B cells, or if instead
other receptors, such as the BCR, consti-
tutively transmit death signals that are
interdicted by the downstream mediators
formed after BAFF-R occupation. This is
an attractive possibility, inasmuch as
BAFF can vary the threshold of BCRsignal
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(Lesley et al., 2004; Thien et al., 2004), but
it generates theconundrumas towhycon-
tinuous so-called tonic BCR signals are
required for quiescent primary B cell
survival.
The notion that interacting TRAFs form
a negative regulatory unit in this survival
system is itself a major conceptual
advance because their amounts can be
modified not only by the BAFF family
receptors themselves but also via addi-
tional TNF members. Thus, the ligation
of other constitutive or induced TNF fam-
ily receptors might decrease, increase,
or eliminate the requirement for BAFF-R
occupation, depending on the TRAFs
involved. For example, TACI, CD40, and
BCMA are all expressed by B cells under
certain conditions, and their ligation will
modify or supersede the need for BAFF-R
ligation by shifting the contemporary stoi-
chiometry of TRAFs.In addition to revealing relationships
among TRAFs that could afford a variety
of context-dependent outcomes, these
considerations point toward a many-
layered system of permutable ligands, re-
ceptors, and substrates that broaden and
nuance potential signaling outcomes. In-
deed, analogous relationships exist both
up- and downstream of TRAF interactions
and together might explain the broad
roles played by BAFF family members.
These possibilities are highlighted in Fig-
ure 1, where the potential contributors at
each layer of interactions are displayed.
The relationships shown or predicted by
Gardam et al. (2008) are indicated by solid
and dashed arrows, respectively. How-
ever, given the array of interacting
elements at each layer, a remarkably
broad range of states can be imagined,
dictated by differentiation subset, activa-
tion status, or microenvironment. For ex-
ample, homotrimeric versus multimericImmunversions of APRIL and BAFF (Bossen
et al., 2008) signal differently, even
through the same receptor. Further, the
varied ligand-binding relationships and
differential distribution of BAFF family re-
ceptors offer another layer of potential
permutations. For example, although na-
ive B cells rely primarily on BAFF-R, B
cells activated through Toll-like receptors
(TLRs) favor TACI expression, and long-
lived bone marrow plasma cells express
BCMA. Each of these TNF family mem-
bers in turn engages a different spectrum
of TRAFs, which themselves can engage
in varied multimeric interactions Finally,
interactions between members of down-
stream signal-transduction components,
such as the classical and nonclassical
NF-kB pathways (Hoffmann et al., 2006),
may yield a final series of possibilities.
This general structure thus allows varied
receptor-input combinations to be speci-
fied by differentiative or exogenous cues
and then integrated through down-
stream systems whose composition and
outcome vary with context.REFERENCES
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Bishop, G.A. (2007). Immunity 27, 253–267.Figure 1. Multiple Layers of Interaction Afford Diverse, Context-Specific Outcomes
Members of the BAFF family of ligands and receptors, the related TNF family receptor CD40, and their
downstream mediators are shown. Alternative trimeric, multimeric, and membrane-bound ligand forms
of APRIL and BAFF are displayed extracellularly. The various combinations of TRAF-binding sites are
shown as circles at the base of each receptor, color matched to their respective TRAFs. The regulatory
relationship suggested by Gardam et al. (2008) is depicted by solid arrows. In this relationship, TRAF2
and TRAF3 interact to block p100 degradation, presumably through interactions with NIK. The binding
of BAFF to BAFF-R interrupts this negative regulatory loop by sequestering and degrading TRAF3, thus
allowing NIK accumulation, p100 degradation, and the subsequent nuclear localization of transcriptionally
active heterodimers of p52 and RelB. Dashed arrows depict additional interactions that would be
predicted to similarly impact this regulatory loop.ity 28, March 2008 ª2008 Elsevier Inc. 301
